182 related articles for article (PubMed ID: 7438324)
1. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
[TBL] [Abstract][Full Text] [Related]
2. Effect of misonidazole in preoperative irradiation for bladder cancer followed by total cystectomy.
Ono K; Akuta K; Takahashi M; Abe M; Nishio Y; Okada K; Yoshida O
Radiat Med; 1989; 7(2):105-9. PubMed ID: 2508190
[TBL] [Abstract][Full Text] [Related]
3. The effects of misonidazole during continuous low dose rate irradiation.
Fu KK; Hurst S; Begg AC; Brown JM
Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
[TBL] [Abstract][Full Text] [Related]
4. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
Hampel N; Persky L
Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. The use of misonidazole in association with a three-fractions per day regimen in advanced head and neck epidermoid cancer. A pilot study.
Awwad HK; Barsoum M; El Merzabani M; Omar S; El Badawy S; Ezzat S; El Baki HA; Zaki A
Am J Clin Oncol; 1983 Feb; 6(1):91-7. PubMed ID: 6301258
[TBL] [Abstract][Full Text] [Related]
8. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
Abratt RP; Sealy R; Tucker RD; Williams MA; Barnes DR; Johnson MB; Green JA; Cridland JS
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with misonidazole: high dose fractions versus daily low doses.
Kogelnik HD
Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
[TBL] [Abstract][Full Text] [Related]
10. The topical use of misonidazole in bladder cancer.
Awwad HK; Abd El Moneim H; Abd El Baki H; Omar S; El Merzabani M; Farag HI
Prog Clin Biol Res; 1983; 132D():305-16. PubMed ID: 6634802
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study.
Smith JA; Crawford ED; Paradelo JC; Blumenstein B; Herschman BR; Grossman HB; Christie DW
J Urol; 1997 Mar; 157(3):805-7; discussion 807-8. PubMed ID: 9072571
[TBL] [Abstract][Full Text] [Related]
12. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
13. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
Koukourakis MI; Tsolos C; Touloupidis S
Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
15. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
Hoskin PJ; Saunders MI; Dische S
Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
[TBL] [Abstract][Full Text] [Related]
17. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
18. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
Awwad HK; Akhoush H; El-Merzabani M; El Badawy S; Barsoum M; el Baki HA
Radiother Oncol; 1984 Jun; 2(1):1-8. PubMed ID: 6095372
[TBL] [Abstract][Full Text] [Related]
19. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
Grdina DJ; Sigdestad CP; Jovonovich JA
Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
[TBL] [Abstract][Full Text] [Related]
20. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]